Not Yet RecruitingNot Applicable

Acceptability of Testing DNA Markers in Vaginal Fluid for the Detection of Endometrial Cancer

United States25 participantsStarted 2026-04-06

Plain-language summary

This study evaluates how women feel about using DNA from a vaginal fluid collection for early detection of endometrial cancer.

Who can participate

Age range45 Years

SexFEMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Self-identified Black individuals ≥ 45 years with an intact uterus * Assigned female sex at birth * Willing to participate in a 30-minute virtual interview Exclusion Criteria: * Previous or current diagnosis of endometrial cancer

What they're measuring

Acceptability of vaginal fluid collection for a DNA-based early detection endometrial cancer test

Timeframe: Baseline (30-minute virtual interview)

Trial details

NCT IDNCT07527143

SponsorMayo Clinic

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2027-04-06

Contact for this trial

Clinical Trials Referral Office

855-776-0015 mayocliniccancerstudies@mayo.edu

View on ClinicalTrials.gov More Endometrial Carcinoma trials